Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis

Background: The implications of different adiposity measures on cardiovascular disease etiology remain unclear. In this article, we quantify and contrast causal associations of central adiposity (waist-to-hip ratio adjusted for body mass index [WHRadjBMI]) and general adiposity (body mass index [BMI]) with cardiometabolic disease. Methods: Ninety-seven independent single-nucleotide polymorphisms for BMI and 49 single-nucleotide polymorphisms for WHRadjBMI were used to conduct Mendelian randomization analyses in 14 prospective studies supplemented with coronary heart disease (CHD) data from CARDIoGRAMplusC4D (Coronary Artery Disease Genome-wide Replication and Meta-analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] Genetics; combined total 66 842 cases), stroke from METASTROKE (12 389 ischemic stroke cases), type 2 diabetes mellitus from DIAGRAM (Diabetes Genetics Replication and Meta-analysis; 34 840 cases), and lipids from GLGC (Global Lipids Genetic Consortium; 213 500 participants) consortia. Primary outcomes were CHD, type 2 diabetes mellitus, and major stroke subtypes; secondary analyses included 18 cardiometabolic traits. Results: Each one standard deviation (SD) higher WHRadjBMI (1 SD≈0.08 U) associated with a 48% excess risk of CHD (odds ratio [OR] for CHD, 1.48; 95% confidence interval [CI], 1.28–1.71), similar to findings for BMI (1 SD≈4.6 kg/m2; OR for CHD, 1.36; 95% CI, 1.22–1.52). Only WHRadjBMI increased risk of ischemic stroke (OR, 1.32; 95% CI, 1.03–1.70). For type 2 diabetes mellitus, both measures had large effects: OR, 1.82 (95% CI, 1.38–2.42) and OR, 1.98 (95% CI, 1.41–2.78) per 1 SD higher WHRadjBMI and BMI, respectively. Both WHRadjBMI and BMI were associated with higher left ventricular hypertrophy, glycemic traits, interleukin 6, and circulating lipids. WHRadjBMI was also associated with higher carotid intima-media thickness (39%; 95% CI, 9%–77% per 1 SD). Conclusions: Both general and central adiposity have causal effects on CHD and type 2 diabetes mellitus. Central adiposity may have a stronger effect on stroke risk. Future estimates of the burden of adiposity on health should include measures of central and general adiposity.

[1]  W. Cates.  HPTN 052 and the future of HIV treatment and prevention , 2011, The Lancet.

[2]  Stephen Burgess,et al.  Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.

[3]  S. Yusuf,et al.  Body-mass index, abdominal adiposity, and cardiovascular risk , 2011, The Lancet.

[4]  Sara M. Willems,et al.  Mendelian Randomization Causal Analysis Adiposity as a Cause of Cardiovascular Disease: a Mendelian Randomization Study *; for the European Network for Genetic and Genomic Epidemiology (engage) Consortium , 2022 .

[5]  Samuli Ripatti,et al.  Metabolic Signatures of Adiposity in Young Adults: Mendelian Randomization Analysis and Effects of Weight Change , 2014, PLoS medicine.

[6]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .

[7]  S. Yusuf,et al.  Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.

[8]  P. Visscher,et al.  Calculating statistical power in Mendelian randomization studies. , 2013, International journal of epidemiology.

[9]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.

[10]  Tom R. Gaunt,et al.  Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis , 2016, The lancet. Diabetes & endocrinology.

[11]  I. Janszky,et al.  BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants , 2016, British Medical Journal.

[12]  S. Ebrahim,et al.  Why Do Thin People Have Elevated All-Cause Mortality? Evidence on Confounding and Reverse Causality in the Association of Adiposity and COPD from the British Women’s Heart and Health Study , 2015, PloS one.

[13]  S. Yusuf,et al.  Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study , 2016, The Lancet.

[14]  Tanya M. Teslovich,et al.  The Metabochip, a Custom Genotyping Array for Genetic Studies of Metabolic, Cardiovascular, and Anthropometric Traits , 2012, PLoS genetics.

[15]  Tom S. Price,et al.  Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. , 2014, American journal of human genetics.

[16]  D. Jacobs,et al.  Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. , 2007, Epidemiologic reviews.

[17]  Sekar Kathiresan,et al.  Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease , 2017, JAMA.

[18]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[19]  A Trichopoulou,et al.  Physical activity and energy intake selectively predict the waist-to-hip ratio in men but not in women. , 2001, The American journal of clinical nutrition.

[20]  Tamara S. Roman,et al.  New genetic loci link adipose and insulin biology to body fat distribution , 2014, Nature.

[21]  G. Davey Smith,et al.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.

[22]  V. Beral,et al.  Coronary heart disease incidence in women by waist circumference within categories of body mass index , 2013, European journal of preventive cardiology.

[23]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[24]  A. Butterworth,et al.  Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways , 2014, International journal of epidemiology.

[25]  Peter Kraft,et al.  Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. , 2015, American journal of human genetics.

[26]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.

[27]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[28]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[29]  N. Timpson,et al.  The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach , 2012, PLoS medicine.

[30]  S. Vansteelandt,et al.  Causal Mediation Analysis with Multiple Mediators , 2014, Biometrics.

[31]  C. Sudlow,et al.  Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies , 2012, The Lancet Neurology.

[32]  Tom R. Gaunt,et al.  The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants , 2008, PloS one.

[33]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[34]  D. Lawlor,et al.  Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits , 2014, International journal of epidemiology.

[35]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[36]  Kurt Hornik,et al.  The Comprehensive R Archive Network , 2012 .

[37]  Matthias F Kriegel,et al.  Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the Rule Out Myocardial Infarction Using Computer Assisted Tomography trial , 2010, Journal of hypertension.

[38]  Sara M. Willems,et al.  Age- and Sex-Specific Causal Effects of Adiposity on Cardiovascular Risk Factors , 2015, Diabetes.

[39]  Christian Gieger,et al.  The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis , 2013, BDJ.

[40]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[41]  B. Gersh.  General and Abdominal Adiposity and Risk of Death in Europe , 2009 .

[42]  D. Lawlor,et al.  Reverse Causality and Confounding and the Associations of Overweight and Obesity with Mortality , 2006, Obesity.

[43]  G. Jensen,et al.  Change in Body Mass Index Associated With Lowest Mortality in Denmark, 1976-2013. , 2016, JAMA.

[44]  J. Després,et al.  Body Fat Distribution and Risk of Cardiovascular Disease: An Update , 2012, Circulation.